Location History:
- Somerset, PA (US) (2011 - 2012)
- Somerset, NJ (US) (2007 - 2019)
- Richboro, PA (US) (2017 - 2023)
Company Filing History:
13 out of 1,025 
12 out of 15 
3 out of 3 Years Active: 2007-2023
Title: Matthew J. Schurman: Innovating Optical Coherence Tomography
Introduction: Matthew J. Schurman, a prolific inventor based in Somerset, NJ, has made significant contributions to the field of optical coherence tomography (OCT). With a remarkable portfolio of 28 patents, his innovations focus on enhancing the monitoring systems for various analytes, showcasing his expertise and dedication to medical technology.
Latest Patents: Among his latest patents, Schurman has developed systems for multispot monitoring in optical coherence tomography. His inventions enable the identification of fluid flow in vivo, such as blood flow, which serves as a crucial metric for assessing blood perfusion in tissue. For instance, when estimating analyte levels like glucose, understanding blood flow can provide insights into the presence of analyte correlating regions suitable for estimation through OCT. This patent also outlines methods for scanning multiple regions of tissue using a distinct optical beam movement, which includes both coarse and fine scanning techniques for detailed analysis.
Another notable patent involves flowometry in optical coherence tomography aimed at analyte level estimation. Schurman continues to emphasize the importance of fluid flow identification in vivo to enhance the efficacy of OCT in medical diagnostics.
Career Highlights: Matthew J. Schurman has held influential roles in notable companies, including Masimo Corporation, where he contributed to cutting-edge medical innovations. His experience in the industry has enabled him to forge a path in technological advancements within medical imaging and patient monitoring.
Collaborations: Throughout his career, Schurman has collaborated with esteemed professionals, including Walter Jeffrey Shakespeare and William Henry Bennett. These collaborations have fostered a productive environment for innovation and the development of groundbreaking technologies in the realm of optical coherence tomography.
Conclusion: Matthew J. Schurman's contributions to optical coherence tomography and medical monitoring systems exemplify the impact of innovative thinking in the medical field. His extensive patent portfolio and collaborative efforts reflect his commitment to advancing technology that can ultimately improve patient care and medical diagnostics.